Combining the pan‐aurora kinase inhibitor <scp>AMG</scp> 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancerChanning J. Paller(Johns Hopkins University), Sushant K. Kachhap(Johns Hopkins University)Cancer MedicineJuly 3, 201410.1002/cam4.289Cited by 30SaveCiteExport RISWatch citationsRelated PapersSelective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer|Oncotarget|2014|63